NorthWest Biotherapeutics Inc (NWBO)

[hodge14]

Sadly iclight you only see things in the most negative light possible and really don't understand how all of this works. I'm probably not going to change that view. JML doesn't even understand the injection schedule, the method A vs. method B time frame, nor the trials' protocol so its impossible to debate.

Patients receive a leukapheresis when they are enrolled. Some patients even have to repeat the procedure if they don't get enough for at least 2-3 injections.

At the conclusion, it is more than likely that not all patients would have 6 injections created from this process. I would say 4 or 5 injections is more likely. I would also guess that all patients that received 6 injections were on the 2M dosage. 6m and 15m would be much harder to get 6 from.

When an injected tumor is dead, there are a number of possible scenarios that are played out. However, if the average patient has 3 tumors, you have quite a few that only have one. What do you think happens when a tumor is injected for a 3rd or 4th time and the biopsy report states the tumor is dead? And by the 3rd or 4th time, they have 3 other "baseline" biopsies to compare information from.

Best wishes.